- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Elevated levels of high-density lipoprotein cholesterol associated with new-onset dementia: Lancet
A new study published in The Lancet Regional Health found that among older adults aged 75 years or above who were initially healthy, elevated levels of high-density lipoprotein cholesterol (HDL-C) were linked to a higher likelihood of experiencing all-cause dementia.
A retrospective analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, a double-blind, placebo-controlled study involving daily low-dose aspirin in healthy older individuals, was conducted. ASPREE enrolled 16,703 participants aged 70 years and older from Australia and 2,411 participants aged 65 years and older from the US between 2010 and 2014. The participants had no diagnosed cardiovascular disease, physical disability, dementia, or life-threatening illness at enrollment, and they were cognitively healthy (3MS score ≥78).
The primary trial endpoint was all-cause dementia, determined by DSM-IV criteria. Cox regression was utilized to examine hazard ratios for dementia across HDL-C categories (<40 mg/dL, 40–60 mg/dL as the reference, 60–80 mg/dL, and >80 mg/dL), and nonlinear associations were assessed using restricted cubic spline curves. Data analysis spanned from October 2022 to January 2023.
Out of the 18,668 participants, 850 cases (4.6%) of new-onset dementia were documented over a span of 6.3 years (with a standard deviation of 1.8 years).
Individuals with elevated HDL-C levels (>80 mg/dL) faced a 27% increased risk of developing dementia. Analyses stratified by age revealed a higher risk of incident dementia in participants aged 75 years or older compared to those below 75 years.
These associations remained statistically significant even after adjusting for various covariates, including age, sex, country of enrollment, daily exercise, education, alcohol consumption, weight changes over time, non-HDL-C, HDL-C-PRS, and APOE genotype.
In summary, the heightened risk of dementia linked to elevated HDL-C levels seemed unrelated to conventional dementia risk factors such as physical activity, alcohol consumption, education, diabetes, or smoking.
Source:
Hussain, S. M., Robb, C., Tonkin, A. M., Lacaze, P., Chong, T. T.-J., Beilin, L. J., Yu, C., Watts, G. F., Ryan, J., Ernst, M. E., Zhou, Z., Neumann, J. T., & McNeil, J. J. (2023). Association of plasma high-density lipoprotein cholesterol level with risk of incident dementia: a cohort study of healthy older adults. The Lancet Regional Health. Western Pacific, 100963, 100963. https://doi.org/10.1016/j.lanwpc.2023.100963
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751